2024
Lessee, Operating Lease, Liability, to be Paid, Year One
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Document Transition Report
Document Transition Report
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate
Expected volatility
Weighted- Average Remaining Contractual Term (In Years), Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Revenue, remaining performance obligation, amount
Revenue, Remaining Performance Obligation, Amount
Term Loan
Term Loan [Text Block]
Term loan.
Geographical [Axis]
Estimated fair value of warrants
Warrants Not Settleable in Cash, Fair Value Disclosure
ASC 606
Accounting Standards Update 2014-09 [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Schedule of Aggregate Fair Values of Warrant Liabilities, for Which Fair Value Determined by Level 3 Inputs
Share-based compensation arrangement by share-based payment award, award vesting period
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period
Cost of Revenue, Total
Cost of Revenue
Related party costs
Increase (Decrease) in Prepaid Expense and Other Assets, Total
Prepaid expenses and other current assets
Increase (Decrease) in Prepaid Expense and Other Assets
Restricted Stock Units
Restricted Stock Units (RSUs) [Member]
Level 1
Fair Value, Inputs, Level 1 [Member]
Series B Conditional Warrants
Series B Conditional Warrants [Member]
Series B conditional warrants.
Fair Value of Financial Assets and Liabilities
Fair Value Disclosures [Text Block]
Commercial purposes at a price of cost plus percentage
Commercial Purposes At Price Of Cost Plus Percentage
Commercial purposes at a price of cost plus percentage.
Income Taxes
Income Tax, Policy [Policy Text Block]
Estimated Useful Life
Property, Plant and Equipment, Useful Life
Revenue from Contract with Customer, Excluding Assessed Tax, Total
Research and development service revenue, related party
Revenue from Contract with Customer, Excluding Assessed Tax
Series C Preferred (As Converted To Common Stock)
Series C Preferred As Converted To Common Stock [Member]
Series C preferred as converted to common stock.
Schedule of other information related to operating leases.
Schedule of Other Information Related to Operating Leases [Table Text Block]
Schedule of Other Information
Class of warrant or right period
Class Of Warrant Or Right Period
Class of warrant or right period.
Property and Equipment Estimated Useful Lives
Property Plant And Equipment Useful Lives Table [Text Block]
Property plant and equipment useful lives.
Shares Available for Future Grant Under Stock Option Plan
Shares Available For Future Grant Under Stock Option Plan [Member]
Shares available for future grant under stock option plan.
Title of Individual
Title of Individual [Domain]
Subsequent events
Subsequent Events [Text Block]
Loan agreement.
Loan Agreement [Member]
Loan Agreement
Schedule of Information About Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Common stock exchange for option exercise
Common Stock Exchange For Option Exercise
Common stock exchange for option exercise.
Operating Lease, Liability, Noncurrent
Lease liability, net of current portion
Technology License Agreement [Abstract]
Technology license agreement.
Schedule of Stock by Class [Table]
Debt Instrument, Unamortized Discount, Total
Debt Instrument, Unamortized Discount
Accretion of debt discount
Less: debt discount
Class of Stock [Line Items]
Total current assets
Assets, Current
Vesting [Domain]
License Agreement [Abstract]
License agreement.
Liabilities and Equity
Total liabilities and stockholders' equity
Entity Address, State or Province
Entity Address, State or Province
Operating Leases, Future Minimum Payments, Due in Two Years
2023
Sale of stock under Shelf
Stock Issued During Period, Value, New Issues
Proceeds from IPO, net
Number Of Stock Options, Shares Outstanding
Number Of Stock Options, Shares Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Trading Symbol
Trading Symbol
Common Stock, Shares, Issued, Total
Common stock issued
Common stock, shares, issued
Common Stock, Shares, Issued
2025
Long-Term Debt, Maturity, Year Two
Aggregate fair value of awards that vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
Prepaid expenses and other current assets
Prepaid Expense and Other Assets, Current
IPO including Underwriters' Option
I P O Including Underwriters Overallotment Option [Member]
IPO including underwriters overallotment option.
Numerator:
Net Income (Loss) Attributable to Parent [Abstract]
Future payment made upon the achievement of sales
Future Payment Made Upon The Achievement Of Sales
Future payment made upon the achievement of sales.
Lease Expiration Date
Lease expiration date
Debt Instrument [Table]
Schedule of Long-Term Debt Instruments [Table]
2026
Lessee, Operating Lease, Liability, to be Paid, Year Three
Common stock reserved for future issuance
Common Stock, Capital Shares Reserved for Future Issuance
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent [Member]
Less current portion
Current portion of term loan payable to a bank
Less current portion
Long-Term Debt, Current Maturities
Long-Term Debt, Current Maturities, Total
Unsecured Debt, Total
Unsecured loan
Unsecured Debt
Entity Address, City or Town
Entity Address, City or Town
2023 (remaining three months)
Long-Term Debt, Maturity, Remainder of Fiscal Year
Number of warrants outstanding
Class of Warrant or Right, Outstanding
Other Long-Term Debt
Debt Disclosure [Text Block]
Summary of Fixed Assets, Net
Property, Plant and Equipment [Table Text Block]
Noncancelable operating lease expiration date.
Noncancelable Operating Lease Expiration Date
Office space noncancelable operating lease expiration date
Non-cash interest expense
Non Cash Interest Expense
Non-cash interest expense.
Debt Instrument, Date of First Required Payment
Debt instrument, commencing date
Government Grants
Government Grants Policy [Text Block]
Government grants.
Subsequent Event
Subsequent Event [Member]
Subsequent Event Type
Subsequent Event Type [Axis]
Share-Based Payment Arrangement, Tranche Two [Member]
Tranche Two
Weighted-Average Exercise Price, Cancelled or forfeited or expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Additional Paid In Capital
Additional Paid-in Capital [Member]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
Accretion of debt discount
Accretion of debt discount.
Current liabilities:
Liabilities, Current [Abstract]
Current assets:
Assets, Current [Abstract]
Preferred stock par value
Preferred Stock, Par or Stated Value Per Share
Impairment, Long-Lived Asset, Held-for-Use, Total
Impairment, Long-Lived Asset, Held-for-Use
Long-lived assets, impairment charge
Class of warrant or right exercise average market price per share.
Class Of Warrant Or Right Exercise Average Market Price Per Share
Class of warrant or right exercise average market price per share
Statement of Stockholders' Equity [Abstract]
Operating Lease, Liability, Current
Current portion of lease liability
Line of Credit Facility, Initiation Date
Loan agreement date
Debt Instrument, Maturity Date
Debt instrument, maturity date
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Fixed assets, net
Fixed assets, net
Property, Plant and Equipment, Net
Cash proceeds Amount Equal to at least from the Issuance and Sale of Equity Securities.
Cash proceeds Amount Equal to at least from the Issuance and Sale of Equity Securities
Cash proceeds amount equal to at least from the issuance and sale of equity securities
Class of Stock
Class of Stock [Domain]
Investment Income, Interest
Interest income
Non-refundable fee
Non Refundable Fee
Non-refundable fee.
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Intrinsic value of stock options vested
Scenario [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Entity Central Index Key
Entity Central Index Key
SHARES OF COMMON STOCK SUBJECT TO WARRANTS
Class of warrants issued
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Plan Name
Plan Name [Domain]
Related Party [Member]
Restricted Cash, Noncurrent
Restricted cash
Schedule of Common Stock Reserved For Future Issuance
Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]
Schedule of common stock reserved for future issuance.
Increase (Decrease) in Other Operating Assets, Total
Increase (Decrease) in Other Operating Assets
Other assets
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding
Preferred stock, Shares outstanding
Preferred stock, shares outstanding
Revenue, remaining performance obligation, expected timing of satisfaction, period
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period
Debt instrument final payment fee
Debt Instrument Final Payment Fee
Final payment fee
Total current liabilities
Liabilities, Current
Entity Tax Identification Number
Entity Tax Identification Number
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Summary of Future Minimum Lease Payments Under Facility Lease
Class of warrant or right consecutive trading days 1.
Class Of Warrant Or Right Consecutive Trading Days 1
Number of consecutive days
Technology License Agreement [Line Items]
Technology License Agreement [Line Items]
Technology license agreement.
Share based compensation arrangement by share based payment award waited average assumptions exercise price.
Share Based Compensation Arrangement by Share Based Payment Award Waited Average Assumptions Exercise Price
Exercise price
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Temporary Equity Stock Issued During Period Value Conversion of Convertible Securities
Temporary equity stock issued during period value conversion of convertible securities.
Temporary equity, Conversion of Series Preferred Stock to common stock
Marketable debt securities maturities duration
Marketable Debt Securities Maturities Duration
Marketable debt securities maturities duration.
Investment, Name [Axis]
Loan, maturity period
Debt Instrument, Term
Loan agreement period
Debt instrument subject to prepayment premium percentage.
Debt Instrument Subject to Prepayment Premium Percentage
Debt instrument subject to prepayment premium percentage
Award Type [Axis]
Award Type
Debt instrument, credit rating
Debt Instrument, Credit Rating
Lessee, Operating Leases [Text Block]
Lease
Unvested Restricted Stock
Restricted Stock [Member]
Class Of Warrant Or Right [Line Items]
Class of Warrant or Right [Line Items]
Plan Name
Plan Name [Axis]
Extended expiration dates
Class Of Warrant Or Right Extended Expiration Dates
Class of warrant or right extended expiration dates.
Geographical [Domain]
Total assets
Assets
Operating Lease, Right-of-Use Asset
Lease right of use asset
Lease right of use assets
Outstanding Stock Options (As Converted To Common Stock)
Stock Options Outstanding [Member]
Stock options outstanding.
Stock Options Outstanding
Entity Registrant Name
Entity Registrant Name
Debt Issuance Costs, Net, Total
Debt Issuance Costs, Net
Debt issuance costs
Paycheck protection program loan forgiveness
Paycheck Protection Program Loan Forgiveness
Paycheck protection program loan forgiveness.
Founders
Executive Officer [Member]
Lessee, Lease, Description [Line Items]
Related Party, Type [Domain]
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Supplemental Cash Flow Information [Abstract]
Supplemental cash flow information:
Patent Costs
Patent Costs Policy [Text Block]
Patent costs.
Summary of Restricted Stock Activity
Nonvested Restricted Stock Shares Activity [Table Text Block]
Accumulated Deficit
Retained Earnings [Member]
Class of Stock
Class of Stock [Axis]
Number of Shares Options, Unvested
Number of Shares Options, Unvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Technology License Agreement
Technology License Agreement [Text Block]
Technology license agreement.
Loss on the sale of fixed assets
Loss on the sale of fixed assets
Gain (Loss) on Disposition of Assets
Gain (Loss) on Disposition of Assets, Total
Percentage income taxes benefits upon ultimate settlement
Percentage Income Taxes Benefits Upon Ultimate Settlement
Percentage income taxes benefits upon ultimate settlement.
Minimum
Minimum [Member]
Minimum [Member]
Proceeds from option exercises
Proceeds from Stock Options Exercised
Summary of Significant Accounting Policies
Significant Accounting Policies [Text Block]
Operating Lease, Liability, Total
Operating Lease, Liability
Lease liability
Operating lease liability
Forecast [Member]
Scenario Forecast
Loan forgiveness
Debt Instrument, Decrease, Forgiveness
Share-Based Payment Arrangement, Tranche One [Member]
Tranche One
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum
Equity Component
Equity Component [Domain]
Common stock held by option holder in consideration of aggregate exercise price
Aggregate Exercise Price Of Common Stock Shares
Aggregate exercise price of common stock shares.
Change in fair value of NC Ohio Trust Warrants
Adjustments to Additional Paid in Capital, Fair Value
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Measurement Frequency
Measurement Frequency [Axis]
EXPIRATION DATES
Expiration dates
Class Of Warrant Or Right Expiration Dates
Class of warrant or right expiration dates.
Debt Disclosure [Abstract]
Debt Instrument, Basis Spread on Variable Rate
Interest rate
Entity Current Reporting Status
Entity Current Reporting Status
Common stock, shares authorized
Common Stock, Shares Authorized
Research and Development Expense, Total
Research and development
Research and Development Expense
Number of product candidates
Number Of Product Candidates
Number of product candidates.
Payment for license fee
Payment For License Fee
Payment for license fee.
Expected dividend assumed
Expected Dividend Assumed
Expected dividend assumed.
Assets
Assets [Abstract]
Net proceeds after deducting underwriting discounts and commissions and offering expenses
Net proceeds
Proceeds from Issuance of Common Stock
Revenue Recognition
Revenue from Contract with Customer [Policy Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Number of shares available for grants
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock, $0.01 par value; 150,000,000 shares authorized at June 30, 2023 and December 31, 2022; 29,042,418 shares issued at June 30, 2023 and December 31, 2022; 28,919,810 shares outstanding at June 30, 2023 and December 31, 2022.
Proceeds from the sale of fixed assets
Proceeds from Sale of Property, Plant, and Equipment
Proceeds from Sale of Property, Plant, and Equipment, Total
Fixed annual rate
Long-Term Debt, Percentage Bearing Fixed Interest, Percentage Rate
Furniture and Fixtures
Furniture and Fixtures [Member]
Long-term debt, measurement input
Long-Term Debt, Measurement Input
Accrued expenses
Accrued expenses
Accrued Liabilities, Current
Current Fiscal Year End Date
Current Fiscal Year End Date
Share-based Payment Arrangement, Noncash Expense, Total
Non-cash stock compensation expense
Share-Based Payment Arrangement, Noncash Expense
Loss from operations
Operating Income (Loss)
Entity Ex Transition Period
Entity Ex Transition Period
Maximum amount upon achievement of various clinical, commercial and sales milestones
Maximum Amount Upon Achievement Of Various Clinical Commercial And Sales Milestones
Maximum amount upon achievement of various clinical, commercial and sales milestones.
Income Tax Expense (Benefit), Total
Income Tax Expense (Benefit)
Income tax expense (benefit)
Income tax provisions or benefits
Research and Development
Research and Development Expense [Member]
Exclusive Licensing Agreement
Exclusive Licensing Agreement [Member]
Exclusive licensing agreement.
Leases
Lessee, Leases [Policy Text Block]
Number of consecutive installments.
Number of Consecutive Installments
Number of consecutive
Accrued Expenses
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Share-Based Payment Arrangement, Expense
Total stock-based compensation expense
Expected volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum
Measurement Input Type
Measurement Input Type [Domain]
Laboratory Equipment
Equipment [Member]
Increase (Decrease) in Operating Lease Liability
Lease liability
Warrants
Warrants Disclosure [Text Block]
Warrants disclosure.
Accounting Standards Update 2016-02 [Member]
ASU 2016-02 (Topic 842)
Temporary Equity Stock Issued During Period Shares Conversion of Convertible Securities
Temporary equity stock issued during period shares conversion of convertible securities.
Temporary equity, Conversion of Series Preferred Stock to common stock, Shares
Temporary equity, Conversion of Series Preferred Stock to common stock, Shares
Impairment of Long-lived Assets
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Aggregate Intrinsic Value, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Total principal
Debt Instrument, Face Amount
Net Loss Per Share
Earnings Per Share, Policy [Policy Text Block]
Operating Leases, Future Minimum Payments, Due in Three Years
2024
Operating Leases, Future Minimum Payments Due, Next 12 Months
2022
Operating expenses:
Operating Expenses [Abstract]
Property, Plant and Equipment [Abstract]
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Significant accounting policies.
Long-term Debt, Type
Long-Term Debt, Type [Domain]
Depreciation, Depletion and Amortization, Nonproduction, Total
Depreciation and amortization expense
Depreciation, Depletion and Amortization, Nonproduction
Subsequent Events [Abstract]
Unvested as of September 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance
Commitments and Contingencies Disclosure [Abstract]
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Significant accounting policies.
Number Of Stock Options, Shares, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Common Stock and Preferred Stock
Equity [Text Block]
Depreciation expense
Depreciation
Depreciation, Total
Legal Entity Type of Counterparty [Domain]
Interest Paid, Excluding Capitalized Interest, Operating Activities
Cash paid for interest
Operating Leases, Rent Expense, Total
Operating Leases, Rent Expense
Rent expense
Equity, Attributable to Parent [Abstract]
Stockholders' equity
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Committed period to remitting in support of clinical trial
Committed Period To Remitting In Support Of Clinical Trial
Committed period to remitting in support of clinical trial.
Line of Credit Facility, Maximum Borrowing Capacity
Loan, maximum borrowing capacity
Summary of Warrants Outstanding for Purchase of Common Stock
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Fair value of common stock
Conditional series B warrants member.
Conditional Series B Warrants [Member]
Conditional Series B Warrants
Earnings Per Share [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Summary of Future Lease Payments Under Non-cancelable Leases
Promissory note contractual interest rate
Promissory Note Contractual Interest Rate
Promissory note contractual interest rate.
Debt, Weighted Average Interest Rate
Weighted average effective interest rate
Investment, Name [Domain]
Promissory Note
Promissory Note [Member]
Promissory note.
Accounting Policies [Abstract]
Lessee, Lease, Description [Table]
Combination of Common Stock, Preferred Stock, Debt Securities, Warrants and/or Units
Combination of Common Stock, Preferred Stock, Debt Securities, Warrants and Units [Member]
Combination of common stock, preferred stock, debt securities, warrants and units.
Liability Class
Liability Class [Axis]
Scenario [Axis]
Concentrations of Credit Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Sale of Stock, Consideration Received on Transaction
Proceeds from stock offering
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Fair value of warrant liability
Warrant liability
Warrant Liability Noncurrent
Warrant liability noncurrent.
Business acquisition carrying value of note
Business Acquisition Carrying Value Of Promissory Note
Business acquisition carrying value of promissory note.
Debt instrument final payment fee percentage.
Debt Instrument Final Payment Fee Percentage
Debt instrument final payment fee percentage
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Net loss per share - basic
BWH License
Brigham And Womens Hospital Inc License Agreement [Member]
Brigham and Womens Hospital, Inc License Agreement.
Commitments and Contingencies
Commitments and contingencies (Note 15)
Income Statement [Abstract]
Common stock capital shares reserved for future issuance descriptions
Common Stock Capital Shares Reserved For Future Issuance Descriptions
Common stock capital shares reserved for future issuance descriptions.
Fixed Assets, Net
Property, Plant and Equipment Disclosure [Text Block]
Related Party, Type [Axis]
Operating Lease, Cost
Operating lease cost
Impairment of fixed assets
Tangible Asset Impairment Charges
Tangible Asset Impairment Charges, Total
Measurement Input Type
Measurement Input Type [Axis]
Statistical Measurement
Statistical Measurement [Domain]
Net cash used in operating activities
Net Cash Provided by (Used in) Operating Activities
ASU 2021-10
Accounting Standards Update 2021-10 [Member]
Payment from related party
Related Party Transaction, Amounts of Transaction
Government [Member]
Government
Ventagen
Ventagen L L C [Member]
Ventagen, LLC.
Asset acquisition, assumption of promissory note.
Asset Acquisition Assumption of Promissory Note
Asset acquisition, assumption of promissory note
All Award Types
All Award Types
Document Period End Date
Document Period End Date
Statistical Measurement
Statistical Measurement [Axis]
Commitments and Contingencies
Commitments and Contingencies Disclosure [Text Block]
Operating Lease, Payments
Operating cash flows used for operating leases
Cash paid for amounts included in measurement of lease liability
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net loss per share - diluted
Asset Acquisition [Axis]
Debt Instrument, Name
Debt Instrument, Name [Domain]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Domain]
Exercisable as of September 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Payment at the time of entering into license
Payment At Time Of Entering Into License
Payment at the time of entering into license.
Related Party Transaction
Related Party Transaction [Domain]
Fair Value, Recurring
Fair Value, Recurring [Member]
Liabilities:
Financial Liabilities Fair Value Disclosure [Abstract]
Loss related to indemnification obligations
Loss Contingency, Loss in Period
Additional Paid in Capital, Common Stock, Ending Balance
Additional Paid in Capital, Common Stock, Beginning Balance
Additional paid-in capital
Additional Paid in Capital, Common Stock
Warrants exercised, Shares
Stock Issued During Period Shares Warrant Exercised
Stock issued during period shares warrant exercised.
Class of warrants shares exercised
Related Party Cost.
Related Party Cost
Related Party Costs
Stock options exercised
Options exercised, Shares
Number Of Stock Options, Shares, Exercised
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Principles of Consolidation
Consolidation, Policy [Policy Text Block]
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Equity
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Lessee operating lease reimbursement of tenant improvement received.
Lessee Operating Lease Reimbursement of Tenant Improvement Received
Lessee operating lease reimbursement of tenant improvement received
Entity Interactive Data Current
Entity Interactive Data Current
Warrants and Rights Note Disclosure [Abstract]
Underwriters’ Overallotment Option
Over-Allotment Option [Member]
Increase (Decrease) in Accounts Payable, Total
Accounts payable
Increase (Decrease) in Accounts Payable
Equity [Abstract]
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: imputed interest
Less: imputed interest
Number of Shares Options, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Weighted-Average Exercise Price, Exercised
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Equity Components
Equity Components [Axis]
Payments for Tenant Improvements
Payments for property modification cost
Upfront license fee
Upfront License Fee
Upfront license fee.
Total
Financial Liabilities Fair Value Disclosure
Weighted-Average Grant Date Fair Value, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Local Phone Number
Local Phone Number
Property Plant And Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Sale of Stock
Sale of Stock [Axis]
Exercisable as of September 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Series B Preferred (As Converted To Common Stock)
Series B Preferred As Converted To Common Stock [Member]
Series B preferred as converted to common stock.
Statement of Cash Flows [Abstract]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Property and Equipment
Property, Plant and Equipment, Policy [Policy Text Block]
Common stock par value
Common stock, par value
Common Stock, Par or Stated Value Per Share
2021 Plan
Two Thousand Twenty One Equity Incentive Plan [Member]
2021 Equity incentive plan.
Deferred revenue
Deferred Revenue, Noncurrent
Deferred Revenue, Noncurrent, Total
Stock-based awards are expected to be recognized over a weighted average period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Axis]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Exclusive licensing agreement with a related party
Collaborative Arrangement Disclosure [Text Block]
Maximum
Maximum [Member]
Temporary equity, shares outstanding
Temporary Equity, Beginning Balance, Shares
Temporary equity, Ending Balance, Shares
Temporary Equity, Shares Outstanding
Emerging Growth Company
Emerging Growth Company Policy [Text Block]
Emerging growth company.
Related Party Transaction
Related Party Transaction [Axis]
Organization and Basis of Presentation
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Level 3
Fair Value, Inputs, Level 3 [Member]
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
Stock-based compensation
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value, Recurring and Nonrecurring [Table]
Change in fair value of warrant liability
Change in fair value of warrant liability
Fair Value Adjustment of Warrants
Net decrease in cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Operating Leases, Future Minimum Payments, Due in Five Years
2026
Payables and Accruals [Abstract]
General and Administrative
General and Administrative Expense [Member]
Incentive to Lessee
Lease incentive
Noncash Investing and Financing Items [Abstract]
Supplemental disclosures of non-cash information:
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease), Total
Change in fair value
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)
Schedule of Potential Shares of Common Stock Excluded from Computation of Diluted Net Loss Per Share
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
City Area Code
City Area Code
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
Cash Flows from Operating Activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
Operating Leases, Future Minimum Payments Due
Total future lease payments
Total future lease payments
Deferred rent
Increase Decrease In Deferred Rent
Increase (decrease) in deferred rent.
Potential future milestone payment
Potential Future Milestone Payment Receivable
Potential future milestone payment receivable.
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total
Less accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
General and Administrative Expense, Total
General and administrative
General and Administrative Expense
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted-average common shares outstanding, basic
Weighted-average shares of common stock outstanding - basic
Unvested as of September 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
Term loan.
Term Loan [Member]
Term Loan
Research and Development Arrangement, Contract to Perform for Others, Type [Domain]
2021 Employee Stock Purchase Plan
Employee Stock [Member]
Cash Flows from Financing Activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Research and Development Costs and Accruals
Research and Development Expense, Policy [Policy Text Block]
Series B Warrants
Series B Warrants [Member]
Series B warrants.
Statement [Table]
Statement [Table]
Schedule of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Cash and Cash Equivalents
Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]
Schedule of Fair Value of Stock Options Granted Was Estimated on Black-Scholes Options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Deferred revenue
Increase (Decrease) in Contract with Customer, Liability
Estimated market rate for unsecured loan
Estimated Market Rate For Unsecured Loan
Estimated market rate for unsecured loan.
Document Fiscal Period Focus
Document Fiscal Period Focus
Lessee, Operating Lease, Liability, to be Paid
Total future lease payments
Total future lease payments
2025
Lessee, Operating Lease, Liability, to be Paid, Year Two
Professional fees and other
Accrued Professional Fees, Current
Statement [Line Items]
Statement [Line Items]
Anti-dilutive securities excluded from computation of earnings per share
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Balance at September 30, 2023
Balance at December 31, 2022
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
Proceeds from Bank Debt
Net proceeds from bank term loan
Lease, Cost, Total
Lease, Cost
Total lease expense
Subsequent Event [Line Items]
Subsequent Event [Line Items]
Warrant [Member]
Warrants
Common Stock
Common Stock [Member]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Grant revenue
Nonoperating Gains (Losses), Total
Grant income
Nonoperating Gains (Losses)
Warrants and Rights Outstanding, Maturity Date
Warrants Expire date
Organization And Basis Of Presentation [Line Items]
Organization And Basis Of Presentation [Line Items]
Organization and basis of presentation.
Cash and Cash Equivalents, at Carrying Value, Ending Balance
Cash and Cash Equivalents, at Carrying Value, Beginning Balance
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value
Schedule of Stock-based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Series B Warrant Liability
Series B Warrant Liability [Member]
Series B warrant liability.
Exercisable as of September 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Expense for startup and patient fees for clinical trials
Expense For Startup And Patient Fees For Clinical Trials
Expense for startup and patient fees for clinical trials.
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Antidilutive Securities, Name
Antidilutive Securities, Name [Domain]
Stock Issued During Period, Value, Conversion of Convertible Securities
Conversion of Series Preferred Stock to common stock
Denominator:
Earning Per Share Basic and Diluted [Abstract]
Earning per share basic and diluted.
Schedule of Principal Payments and Net Carrying Amount of Term Loan
Schedule of Debt [Table Text Block]
Treasury stock (at cost)
Treasury Stock, Value
Treasury Stock, Value, Total
Cover [Abstract]
Vesting [Axis]
Document Fiscal Year Focus
Document Fiscal Year Focus
Income Taxes Paid, Net, Total
Cash paid for taxes
Income Taxes Paid, Net
Sale of Stock
Sale of Stock [Domain]
Series A Warrants
Series A Warrants [Member]
Series A warrants.
Legal Entity of Counterparty, Type [Axis]
Outstanding Warrants For Common Stock
Outstanding Warrants For Common Stock [Member]
Outstanding warrants for common stock.
Stock-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Weighted-Average Grant Date Fair Value, Granted
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Paycheck Protection Program, CARES Act
Paycheck Protection Program C A R E S Act [Member]
Paycheck Protection Program, CARES Act.
Security Exchange Name
Security Exchange Name
Share-based compensation arrangement by share-based payment award, expiration period
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period
New Accounting Pronouncements, Policy [Policy Text Block]
Recently adopted accounting standards
Preferred Stock, Shares Issued, Total
Preferred stock, Shares issued
Preferred Stock, Shares Issued
Preferred stock, shares issued
Preferred stock, shares authorized
Preferred Stock, Shares Authorized
Property, Plant and Equipment, Gross, Ending Balance
Property, Plant and Equipment, Gross, Beginning Balance
Property, Plant and Equipment, Gross, Total
Total fixed assets
Property, Plant and Equipment, Gross
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Lease liability arising from obtaining right-of-use assets
Treasury stock acquired, Shares
Treasury stock acquired, Shares
Treasury Stock, Shares, Acquired
Warrants exercised
Stock Issued During Period Value Warrant Exercised
Stock issued during period value warrant exercised.
Due from Related Party
Due from Related Party
Due from related parties
Class Of Warrant Or Right [Table]
Class of Warrant or Right [Table]
Options exercised
Stock Issued During Period, Value, Stock Options Exercised
Entity Emerging Growth Company
Entity Emerging Growth Company
Long-term debt, due month and year
Long Term Debt Due Month And Year
Long term debt due month and year.
Convertible preferred stock converted into common stock
Convertible preferred stock converted into common stock
Convertible Preferred Stock, Shares Issued upon Conversion
Amendment Flag
Amendment Flag
Schedule of Accrued Expenses
Schedule of Accrued Liabilities [Table Text Block]
IPO
IPO [Member]
Public float issuing securities
Public Float Issuing Securities
Public Float Issuing Securities
Accounting Standards Update
Accounting Standards Update [Domain]
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Periphagen, Inc. asset acquisition.
Periphagen Inc Asset Acquisition [Member]
Periphagen, Inc.
Related party transactions, ownership percentage
Equity Method Investment, Ownership Percentage
Leases [Abstract]
Licensing agreement clinical trial period
Licensing Agreement Clinical Trial Period
Licensing agreement clinical trial period.
Variable Rate [Domain]
Debt instrument accretion of debt discount.
Debt Instrument Accretion of Debt Discount
Accretion of debt discount
Entity File Number
Securities Act File Number
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Past services provided by beneficiary
Past Services Provided By Beneficiary
Past services provided by beneficiary.
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Table]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]
ATM Program
At-the-Market Offering [Member]
At-the-market offering.
Additional variable consideration amount payable to customer
Additional Variable Consideration Amount Payable To Customer
Additional variable consideration amount payable to customer.
2023
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Long-term portion
Long-Term Debt, Excluding Current Maturities
Long-Term Debt, Excluding Current Maturities, Total
Line of Credit Facility [Abstract]
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
2015 Plan
Two Thousand Fifteen Stock Plan [Member]
2015 Stock Plan.
Class of warrant or right exercise price per share.
Class Of Warrant Or Right Exercise Price Per Share
Class of warrant or right exercise price per share
Other Assets, Total
Other Assets
Other assets
Share-Based Payment Arrangement [Abstract]
Operating Leases, Future Minimum Payments, Due in Four Years
2025
Accounts Payable, Current, Total
Accounts payable
Accounts Payable, Current
Debt Instrument [Axis]
Debt Instrument
Weighted-Average Grant Date Fair Value, Unvested
Weighted-Average Grant Date Fair Value, Unvested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Other Receivables
Due from related parties
Total operating expenses
Operating Expenses
2024
Long-Term Debt, Maturity, Year One
Series C Convertible Preferred Stock
Series C Convertible Preferred Stock [Member]
Series C convertible preferred stock.
Business acquisition present value of future cash outflow
Business Acquisition Present Value Of Future Cash Outflow
Business acquisition present value of the future cash outflow.
Expected option life (years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Reverse stock split
Stockholders' Equity, Reverse Stock Split
Entity Address, Address Line Two
Entity Address, Address Line Two
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued
Preferred stock, $0.01 par value; 10,000,000 shares authorized at June 30, 2023 and December 31, 2022; no shares issued or outstanding at June 30, 2023 and December 31, 2022, respectively.
Entity Small Business
Entity Small Business
Entity Shell Company
Entity Shell Company
Number of Operating Segments
Number of operating segment
Title of Individual
Title of Individual [Axis]
EXERCISE PRICE PER SHARE
Exercise price per share
Class of warrants issued per share
Class of Warrant or Right
Class of Warrant or Right [Domain]
Unrecognized compensation cost related to unvested stock options
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Networking and Computer Equipment
Computer Equipment [Member]
Net Loss Per Share
Earnings Per Share [Text Block]
Number Of Stock Options, Shares, Cancelled or forfeited or expired
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Total
Entity Address, Address Line One
Entity Address, Address Line One
Antidilutive Securities
Antidilutive Securities [Axis]
Other Liabilities, Current, Total
Other current liabilities
Other Liabilities, Current
Non-cash lease expense
Non-cash lease expense.
Restricted Cash, Total
Restricted cash
Restricted Cash
Subsequent Event Type
Subsequent Event Type [Domain]
Risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum
Income Statement Location
Income Statement Location [Axis]
Variable Lease, Cost
Variable lease cost
2026
Long-Term Debt, Maturity, Year Three
Risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum
Series B Convertible Preferred Stock
Series B Convertible Preferred Stock [Member]
Series B Convertible Preferred Stock.
Expected dividend yield
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Long-term Debt, Type
Long-Term Debt, Type [Axis]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total
Net loss
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Maximum percentage of shares reserved increase annually of outstanding shares of common stock
Maximum Percentage Of Shares Reserved Increase Annually Of Outstanding Shares Of Common Stock
Maximum percentage of shares reserved increase annually of outstanding shares of common stock.
Debt Instrument, Frequency of Periodic Payment
Debt instrument, payment
Level 2
Fair Value, Inputs, Level 2 [Member]
Schedule Of Collaborative Arrangements And Noncollaborative Arrangement Transactions [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Committed amount to remitting in support of clinical trial
Committed Amount To Remitting In Support Of Clinical Trial
Committed amount to remitting in support of clinical trial.
Net carrying amount
Total principal
Long-Term Debt, Gross
Long-term debt
Treasury stock acquired
Treasury Stock, Value, Acquired, Cost Method
Title of 12(b) Security
Title of 12(b) Security
Convertible preferred stock
Temporary Equity, Beginning Balance
Temporary equity, Ending Balance
Temporary Equity, Carrying Amount, Attributable to Parent
Accrued interest due upon maturity period
Accrued Interest Due Upon Maturity Period
Accrued interest due upon maturity period.
Prime Rate [Member]
Prime Rate
Unvested as of September 30, 2023
Sharebased Compensation Arrangement By Sharebased Payment Award Option Unvested Weighted Average Remaining Contractual
Share based compensation arrangement by share based payment award option unvested weighted average remaining contractual.
Accounting Standards Update
Accounting Standards Update [Axis]
Treasury Stock, Common [Member]
Treasury Stock Member
Cash Flows from Investing Activities:
Net Cash Provided by (Used in) Investing Activities [Abstract]
Laboratory Equipment
Laboratory Equipment [Member]
Laboratory equipment.
Area of lease property
Area Of Lease Property
Area of lease property.
Segment Reporting, Policy [Policy Text Block]
Segment Information
Long-Lived Tangible Asset
Long-Lived Tangible Asset [Domain]
Subsequent Event [Table]
Subsequent Event [Table]
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Share-Based Payment Arrangement, Tranche Three [Member]
Tranche Three
Interest Expense, Debt, Total
Interest Expense, Debt
Interest expense
Exercisable as of September 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Common stock, shares, outstanding
Beginning Balance, Shares
Ending Balance, Shares
Common Stock, Shares, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Risk-free interest rate
Stock Options, Restricted Stock and Stock-Based Compensation
Share-Based Payment Arrangement [Text Block]
Weighted-Average Grant Date Fair Value, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Payment for annual license fee
Payment For Annual License Fee
Payment for annual license fee.
Proceeds from warrant exercises
Proceeds from Warrant Exercises
Measurement Input, Credit Rate
Measurement Input Credit Rate [Member]
Measurement input credit rate.
Income Statement Location
Income Statement Location [Domain]
Weighted-Average Exercise Price, Granted
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Document Type
Document Type
Stock Issued During Period, Shares, Conversion of Convertible Securities
Conversion of Series Preferred Stock to common stock, Shares
Accounting Standards Update 2020-06 [Member]
ASU 2020-06
Fair Value by Liability Class
Fair Value by Liability Class [Domain]
Net Cash Provided by (Used in) Investing Activities
Net cash used in investing activities
Document Quarterly Report
Document Quarterly Report
Warrant liability
Warrants and Rights Outstanding
Unsecured Note
Unsecured Debt [Member]
Number of Shares Options, Forfeited
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Net cash provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Other Long-Term Debt, Noncurrent
Other long-term debt
Entity Filer Category
Entity Filer Category
Share based compensation award tranche four member.
Share Based Compensation Award Tranche Four [Member]
Tranche Four
Other long term assets
Increase (Decrease) in Other Noncurrent Assets
Increase (Decrease) in Accrued Liabilities, Total
Accrued expenses
Increase (Decrease) in Accrued Liabilities
Borrowings under Paycheck Protection Program
Subordinated Borrowings Disclosure [Text Block]
Corporate, Clinical and Manufacturing Operations
Corporate Clinical And Manufacturing Operations [Member]
Corporate clinical and manufacturing operations.
Variable Rate [Axis]
Voting stock.
Voting Stock [Member]
Voting Stock
Total other income (expense), net
Nonoperating Income (Expense)
Capital expenditures in accounts payable and accrued expenses
Capital Expenditures Incurred but Not yet Paid
Total liabilities
Liabilities
Schedule Of Property Plant And Equipment [Table]
Property, Plant and Equipment [Table]
MASSACHUSETTS
Massachusetts
Beginning Balance
Ending Balance
Equity, Attributable to Parent
Total stockholders' equity
Loans Payable to Bank, Noncurrent
Term loan payable to a bank
Net carrying amount
Net carrying amount
Net loss and comprehensive loss
Net loss
Net Income (Loss)
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Interest Expense, Total
Interest Expense
Interest expense
Interest expense
Unvested as of September 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award Options Non-vested Intrinsic Value
Share-based compensation arrangement by share-based payment award options non-vested intrinsic value.
Proceeds from Issuance Initial Public Offering
Net proceeds from initial public offering
Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]
Class of warrant or right issued
Class Of Warrant Or Right Issued
Class of warrant or right issued.
Third-party research and development expenses
Accrued Third Party Research And Development Expenses Current
Accrued third-party research and development expenses current.
Interest income.
Interest Income
Interest income
Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]
Fair Value Measurements
Fair Value Measurement, Policy [Policy Text Block]
Cash and cash equivalent maturity period
Cash And Cash Equivalent Maturity Period
Cash and cash equivalent maturity period.
Statement of Financial Position [Abstract]
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted-average common shares outstanding, diluted
Weighted-average shares of common stock outstanding - diluted
Asset Acquisition [Domain]
Organization And Basis Of Presentation [Table]
Organization And Basis Of Presentation [Table]
Organization and basis of presentation.
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease term (years)
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Income taxes
Income Tax Disclosure [Text Block]
Manufacturing equipment
Manufacturing Equipment [Member]
Manufacturing Equipment
Weighted-Average Exercise Price, Outstanding
Weighted-Average Exercise Price, Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted-average incremental borrowing rate.
Weighted-average Incremental Borrowing Rate
Weighted-average incremental borrowing rate
Unaudited Interim Financial Information
Unaudited Interim Financial Information Policy [Text Block]
Unaudited interim financial information.
Schedule of Basic and Diluted Net Loss Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Leasehold Improvements
Leasehold Improvements [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Fair Value Disclosures [Abstract]
Fair Value Hierarchy and NAV
Fair Value Hierarchy and NAV [Axis]
Measurement Frequency
Measurement Frequency [Domain]
Payments to Acquire Property, Plant, and Equipment, Total
Purchase of fixed assets
Payments to Acquire Property, Plant, and Equipment
NC Ohio Trust
N C Ohio Trust Warrants [Member]
NC Ohio trust warrants.
Number of Shares Options, Vested
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Stock Issued During Period, Shares, New Issues
Proceeds from IPO, net, Shares
Employee-related Liabilities, Current, Total
Payroll and employee related expenses
Employee-related Liabilities, Current
Class of Warrant or Right
Class of Warrant or Right [Axis]
Income Tax Disclosure [Abstract]
Accounting standards update 2020 05.
Accounting Standards Update 2020 05 [Member]
ASU 2020-05